Since LD patients are not only at risk for cardiovascular events and diabetes, but also have an increased morbidity and mortality due to other complications e.g., acute pancreatitis and liver failure [35], increased GDF15 levels might be a predictor for elevated overall morbidity and mortality in LD. The gene discussed is GDF15; the disease is diabetes mellitus.